Key facts
- NSV Partners III LP filed SCHEDULE 13D/A for Ventyx Biosciences, Inc. Common stock, par value $0.0001 per share (VTYX).
- Disclosed ownership: 5.7%.
- Date of event: 28 Mar 2025.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| NSV Partners III, L.P. | 4.5% | 3,189,270 | 0 | 3,189,270 | /s/ Tom Lavin | Tom Lavin/Partner | 0001890004 |
| NSV Partners III GP, LLC | 4.5% | 3,189,270 | 0 | 3,189,270 | /s/ Tom Lavin | Tom Lavin/Partner | 0001889601 |
| Subramaniam Somu | 5.7% | 4,089,975 | 57,762 | 4,032,213 | /s/ Somasundaram Subramaniam | Somasundaram Subramaniam | 0001508910 |
CIK / CUSIP context first